Survivor Profile An Unlikely Pivot Medha Deoras-Sutliff’s experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers. by Lindsey Konkel Survivor Profile Sharing Her Strength Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer. by Lindsey Konkel Survivor Profile A Driving Force Mark Good uses every avenue to spread the news about prostate cancer. by Lindsey Konkel Survivor Profile Handle With Care Brain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone. by Lindsey Konkel Survivor Profile A Sister’s Circle School counselor Diane Nathaniel creates communities for herself and those around her in Brooklyn and beyond. Her cancer diagnosis led her into patient advocacy. by Marci A. Landsmann Survivor Profile Still in the Game ESPN reporter Holly Rowe worked through melanoma treatment. by Lindsey Konkel Survivor Profile A Lesson in Service Rabbi Ben David was comfortable in his role of helping those in need, but he had to rely on others after his lymphoma diagnosis. The marathon runner has returned to an active life one step at a time. by Lindsey Konkel Survivor Profile The Bridge Builder Breast cancer survivor Bob Riter forges connections among people affected by all types of cancer. by Marci A. Landsmann Survivor Profile The Power of Patients Janet Freeman-Daily helps put patients at the center of lung cancer research. by Robin Meadows Survivor Profile A Long Road Back Multiple myeloma survivor Gary Lambert deploys inventiveness and fortitude to deal with cancer. by Lindsey Konkel next Cancer Talk Why Do African Americans Have Increased Breast Cancer Mortality? Socioeconomic factors and racism can lead to poorer health outcomes for Black Americans. Genetics may also be a factor behind increased mortality rates. by Marci A. Landsmann Liquid Biopsies May Ease Enrollment in Clinical Trials A study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials. by Emma Yasinski What Is Tumor Mutational Burden? The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it’s not clear the biomarker is valid across all cancer types. by Anna Azvolinsky Drafting a Medical Team Going through cancer treatment and ensuing complications is never easy, but surrounding yourself with the right key players can help, writes pancreatic cancer survivor Rob Weker. by Rob Weker More Posts